Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cocaine and Vigabatrin

supplement:

Cocaine

Research Papers that Mention the Interaction

An open-label clinical trial in humans suggested that GVG may reduce cocaine and methamphetamine use.
Pharmacology Biochemistry and Behavior  •  2009  |  View Paper
In particular, animal models of both cocaine and alcohol dependence have demonstrated significant decreases in consumption of both substances after administration of vigabatrin at doses that did not impact motor activity, suggesting potential use as a therapeutic agent for cocaine or alcohol use disorders (2, 3).
The American journal of psychiatry  •  2009  |  View Paper
Although no effective medication currently exists for its treatment, racemic γ vinyl‐GABA (R,S‐GVG, vigabatrin) shows enormous potential as it blocks both the neurochemical and behavioral effects of a variety of drugs, including METH, heroin, morphine, ethanol, nicotine, and cocaine.
Synapse  •  2009  |  View Paper
Previous studies demonstrate that gamma-vinyl GABA GVG ), an irreversible GABA transaminase inhibitor, attenuates the acute rewarding effects of cocaine and other addictive drugs.
These data suggest …: (1) GVG significantly … cocaine- or sucrose-triggered reinstatement of reward-seeking behavior; and (2) a GABAergic-, but not dopaminergic-, dependent mechanism may underlie the antagonism by GVG of cocaine-triggered reinstatement of drug-seeking behavior, at least with respect to GVG's action on the NAc.
We here report that systemic administration of GVG (25-300 mg/kg) dose-dependently inhibits cocaine- or sucrose-induced reinstatement of reward-seeking behavior in rats.
Drug and alcohol dependence  •  2008  |  View Paper
Gabapentin (1-30 mg/kg), tiagabine (2.5-10 mg/kg) or vigabatrin (75-250 mg/kg) attenuated the cocaine (10 mg/kg)-induced hyperactivation and in the highest doses they also decreased basal locomotor activation.
European journal of pharmacology  •  2006  |  View Paper
ResultsSub-chronic GVG exposure inhibited the effect of cocaine for 3 days, which exceeded in magnitude and duration the identical acute dose.
Psychopharmacology  •  2003  |  View Paper
Since sensitization may be one of the factors involved in relapse to drug use, the present results, in combination with previous findings that GVG blocks the rewarding and incentive motivating effects of cocaine , suggest that GVG might prove useful in the treatment of cocaine addiction.
Synapse  •  2002  |  View Paper
The results of these experiments showed that GVG , at doses of 100, 200 and 300 mg/kg, reduced both ethanol and cocaine consumption in a dose-related manner.
Pharmacology Biochemistry and Behavior  •  2001  |  View Paper
In a series of microdialysis experiments in freely moving animals, S(+)-GVG (150 mg/kg), R(-)-GVG (150 mg/kg) or racemic (R, S) GVG (300 mg/kg) was administered 2.5 hours prior to cocaine (20 mg/kg) administration.
Life sciences  •  2000  |  View Paper
It was therefore important to assess if there was an enhanced toxicity from the combination of GVG with cocaine.
Life sciences  •  1999  |  View Paper
Show More